Your browser doesn't support javascript.
loading
Bortezomib, Melphalan, and Prednisone With or Without Daratumumab in Transplant-ineligible Asian Patients With Newly Diagnosed Multiple Myeloma: The Phase 3 OCTANS Study.
Fu, Weijun; Bang, Soo-Mee; Huang, Honghui; Kim, Kihyun; Li, Wei; An, Gang; Lee, Je-Jung; Cai, Zhen; Jin, Jie; Wang, Yafei; Lin, Tung-Liang; Chim, Chor Sang; Qi, Ming; Wang, Jianping; Lu, Xiaolin; Song, Yang; Jia, Bin; Yang, Xue; Liu, Wenyu; Zhou, Tianyuan; Yin, Lu; Li, Yunan; Zhang, Renyi; Hou, Jian; Wang, Jianxiang.
Afiliação
  • Fu W; Department of Hematology, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, China; Department of Hematology, Changzheng Hospital, Shanghai, China.
  • Bang SM; Seoul National University Bundang Hospital, Seongnam, South Korea.
  • Huang H; Department of Hematology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Kim K; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Li W; Department of Hematology at the Oncology Center, The First Hospital of Jilin University, Changchun, China.
  • An G; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
  • Lee JJ; Department of Hematology-Oncology, Chonnam National University Medical School, Hwasun, Jeollanamdo, South Korea.
  • Cai Z; The First Affiliated Hospital of Zhejiang University, College of Medicine, Hangzhou, Zhejiang, China.
  • Jin J; The First Affiliated Hospital of Zhejiang University, College of Medicine, Hangzhou, Zhejiang, China.
  • Wang Y; Tianjin Cancer Hospital, Tianjin, China.
  • Lin TL; Chang Gung Memorial Hospital, Taoyuan City, Taiwan.
  • Chim CS; Hong Kong Sanatorium & Hospital, Hong Kong.
  • Qi M; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Wang J; Janssen Research & Development, LLC, Raritan, NJ, USA.
  • Lu X; Janssen Research & Development, LLC, Beijing, China.
  • Song Y; Janssen Research & Development, LLC, Beijing, China.
  • Jia B; Janssen Research & Development, LLC, Shanghai, China.
  • Yang X; Janssen Research & Development, LLC, Shanghai, China.
  • Liu W; Janssen Research & Development, LLC, Beijing, China.
  • Zhou T; Janssen (China) Research & Development, AP Center of Excellence, Translational Science, Shanghai, China.
  • Yin L; Janssen Research & Development, LLC, Beijing, China.
  • Li Y; Medical Affairs, Xian Janssen Pharmaceutical Ltd., Beijing, China.
  • Zhang R; Medical Affairs, Xian Janssen Pharmaceutical Ltd., Shanghai, China.
  • Hou J; Department of Hematology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. Electronic address: houjian@medmail.com.cn.
  • Wang J; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China. Electronic address: wangjx@ihcams.ac.cn.
Clin Lymphoma Myeloma Leuk ; 23(6): 446-455.e4, 2023 06.
Article em En | MEDLINE | ID: mdl-37024420
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombocitopenia / Mieloma Múltiplo Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombocitopenia / Mieloma Múltiplo Idioma: En Ano de publicação: 2023 Tipo de documento: Article